Veterinary Medicines

Alizin 30 mg/ml Solution for Injection

Authorised
  • Aglepristone
Download as PDF

Product identification

Medicine name:
Alizin 30 mg/ml Solution for Injection
Alizin vet. 30 mg/ml injeksjonsvæske, oppløsning
Active substance:
  • Aglepristone
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Aglepristone
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG03XB90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Vial (glass, type II) of 5 ml for injectable preparation, with bromobutyl stopper and aluminum cap. Presentation: - box of 1 vial of 5ml
  • Vial (glass, type II) of 10 ml for injectable preparation, with bromobutyl stopper and aluminum cap. Presentation: - box of 1 vial of 10ml.
  • Vial (glass, type II) of 30 ml for injectable preparation, with bromobutyl stopper and aluminum cap. Presentation: - box of 1 vial of 30ml.
  • Vials (glass, type II) of 10 ml for injectable preparations, with bromobutyl stoppers and aluminum caps. Presentation: - box of 10 vials of 10ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • Norwegian Medicines Agency
Authorisation number:
  • 03-2047
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0500/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Norwegian (PDF)
Published on: 6/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 6/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."